Defining the Regulatory Pathway for a Novel 3D Imaging Technology
Guiding a Pioneering Technology Through FDA Strategy and Clinical Alignment A medical device innovator developing a novel, ultrasound-based technology to evaluate organ tissue characteristics approached AlvaMed with a critical challenge: defining a viable FDA regulatory pathway for a device with no clear predicate and a complex clinical strategy with trials already underway in advance of […]
Strengthening FDA Inspection Readiness Through Targeted QMSR & ISO 13485 Training
Overview A mid-sized medical device organization engaged AlvaMed to deliver a targeted, full-day training program focused on the FDA’s Quality Management System Regulation (QMSR), ISO 13485, and evolving inspection methodologies. The engagement followed recent regulatory scrutiny, including FDA Warning Letters and inspection observations (Form 483), creating an urgent need to strengthen internal quality system understanding […]
Case Study: Streamlining 510(k) Clearance for an Endoscopy Accessory
Background: A late-stage medical device company, specializing in gastrointestinal solutions, developed an innovative vacuum attachment for existing endoscopes. This accessory, designed to enhance procedural capabilities, required 510(k) clearance for market entry. The company sought expert regulatory guidance to navigate the submission process efficiently. Challenge: The company faced two key challenges: Approach: AlvaMed provided comprehensive regulatory […]
CER and Literature Search Remediation
Challenge: Approach: AlvaMed implemented the following approach: Results: AlvaMed delivered the following: Impact: Project is a heavy time burden and lift for a company, especially if they are limited with resources to dedicate to this type of remediation effort. Also, it allows a group of experts to step in, who deal with these types of […]
Case Study: Navigating Regulatory Challenges to Achieve FDA Clearance
Background and Challenge: A medical device manufacturer sought FDA clearance for its innovative lidocaine delivery device designed to deliver aerosolized lidocaine to the upper airway to facilitate office-based procedures. The company initially engaged with a different consulting company to prepare and submit the 510(k) application. However, after receiving an Additional Information Needed (AIN) letter from […]
Clinical Strategy & Protocol Development
Challenge: A small company specializing in an innovative robotic platform technology for precision surgery in oncology approached AlvaMed for CRO support. The client’s goals were to develop a clinical strategy and a study protocol with support documents (consent, Case Report Forms (CRFs), regulatory documentation) aligned with that strategy. Additionally, they wanted to have a study-ready […]
Internal Auditing
Background and Problem A small start-up with limited resources needed assistance with conducting its required internal audits to maintain compliance with quality and regulatory requirements. The scope of the organization’s quality management system includes ISO 13485:2016 and 21 CFR Parts 820, 803, & 806. Due to the size of the organization and the operating mode, […]
Device Classification
Background and Problem A US based manufacturer of sample preparations reagents and instruments needed an outside opinion of their regulatory compliance regarding labeling certain devices as “Research Use Only (RUO)” in the United States and the European Union. The manufacturer also wanted assistance to develop an approach on how best to register and list a […]
Regulatory Strategy & 510(k) Submission Support
CHALLENGE: A new US based division manufacturer of a Chinese dental implant, wanted to grow their business by bringing their product, material used in the construction of dental implants, to the US market. With no prior experience in US medical device regulations, they needed assistance determining the best regulatory path and guidance to navigate the […]
ACLA’s Bold Move: Challenging FDA’s Final Rule on LDTs
In a groundbreaking legal maneuver, the American Clinical Laboratory Association (ACLA) has filed the first lawsuit in an attempt to block the implementation of the Food and Drug Administration’s (FDA) Final Rule on Laboratory Developed Tests (LDTs). The contentious Final Rule, which aims to regulate LDTs, has sparked heated debates within the healthcare and regulatory […]
